Suppr超能文献

使用基于CRISPR-Cpf1的转录因子进行可诱导和多重基因调控。

Inducible and multiplex gene regulation using CRISPR-Cpf1-based transcription factors.

作者信息

Tak Y Esther, Kleinstiver Benjamin P, Nuñez James K, Hsu Jonathan Y, Horng Joy E, Gong Jingyi, Weissman Jonathan S, Joung J Keith

机构信息

Molecular Pathology Unit, Center for Cancer Research, and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.

Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Nat Methods. 2017 Dec;14(12):1163-1166. doi: 10.1038/nmeth.4483. Epub 2017 Oct 30.

Abstract

Targeted and inducible regulation of mammalian gene expression is a broadly important capability. We engineered drug-inducible catalytically inactive Cpf1 nuclease fused to transcriptional activation domains to tune the expression of endogenous genes in human cells. Leveraging the multiplex capability of the Cpf1 platform, we demonstrate both synergistic and combinatorial gene expression in human cells. Our work should enable the development of multiplex gene perturbation library screens for understanding complex cellular phenotypes.

摘要

对哺乳动物基因表达进行靶向和诱导调控是一项具有广泛重要性的能力。我们设计了与转录激活结构域融合的药物诱导型催化失活Cpf1核酸酶,以调节人类细胞中内源基因的表达。利用Cpf1平台的多重功能,我们在人类细胞中展示了协同和组合基因表达。我们的工作应能推动多重基因扰动文库筛选的发展,以了解复杂的细胞表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7e5/5909187/0e9d55bb2c5d/nihms911266f1.jpg

相似文献

1
Inducible and multiplex gene regulation using CRISPR-Cpf1-based transcription factors.
Nat Methods. 2017 Dec;14(12):1163-1166. doi: 10.1038/nmeth.4483. Epub 2017 Oct 30.
2
Efficient Transcriptional Gene Repression by Type V-A CRISPR-Cpf1 from Eubacterium eligens.
ACS Synth Biol. 2017 Jul 21;6(7):1273-1282. doi: 10.1021/acssynbio.6b00368. Epub 2017 Apr 11.
3
In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens.
Nat Methods. 2019 May;16(5):405-408. doi: 10.1038/s41592-019-0371-5. Epub 2019 Apr 8.
4
Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells.
Nat Biotechnol. 2016 Aug;34(8):863-8. doi: 10.1038/nbt.3609. Epub 2016 Jun 6.
5
Tamoxifen- and Mifepristone-Inducible Versions of CRISPR Effectors, Cas9 and Cpf1.
ACS Synth Biol. 2018 Sep 21;7(9):2160-2169. doi: 10.1021/acssynbio.8b00145. Epub 2018 Sep 4.
6
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
Nat Biotechnol. 2016 Aug;34(8):869-74. doi: 10.1038/nbt.3620. Epub 2016 Jun 27.
7
Cas9, Cpf1 and C2c1/2/3-What's next?
Bioengineered. 2017 May 4;8(3):265-273. doi: 10.1080/21655979.2017.1282018. Epub 2017 Jan 31.
8
Advances in therapeutic CRISPR/Cas9 genome editing.
Transl Res. 2016 Feb;168:15-21. doi: 10.1016/j.trsl.2015.09.008. Epub 2015 Sep 26.
9
Gene activation in human cells using CRISPR/Cpf1-p300 and CRISPR/Cpf1-SunTag systems.
Protein Cell. 2018 Apr;9(4):380-383. doi: 10.1007/s13238-017-0491-6.
10
CRISPR RNA-guided activation of endogenous human genes.
Nat Methods. 2013 Oct;10(10):977-9. doi: 10.1038/nmeth.2598. Epub 2013 Jul 25.

引用本文的文献

1
Conformational changes induced by K949A mutation in the CRISPR-Cas12a complex drives an effective target-binding mechanism.
Curr Res Struct Biol. 2025 Aug 8;10:100173. doi: 10.1016/j.crstbi.2025.100173. eCollection 2025 Dec.
2
Programmable genome engineering and gene modifications for plant biodesign.
Plant Commun. 2025 Aug 11;6(8):101427. doi: 10.1016/j.xplc.2025.101427. Epub 2025 Jun 24.
3
Harnessing CRISPR potential for intervertebral disc regeneration strategies.
Front Bioeng Biotechnol. 2025 May 8;13:1562412. doi: 10.3389/fbioe.2025.1562412. eCollection 2025.
4
Array Assembler Provides Greatly Simplified crRNA Array Design for CRISPR Cas12 and Cas13 Variants.
ACS Synth Biol. 2025 May 16;14(5):1868-1872. doi: 10.1021/acssynbio.5c00100. Epub 2025 May 7.
5
A systematic screening assay identifies efficient small guide RNAs for CRISPR activation.
Front Bioeng Biotechnol. 2025 Jan 23;13:1336313. doi: 10.3389/fbioe.2025.1336313. eCollection 2025.
8
Biology and applications of CRISPR-Cas12 and transposon-associated homologs.
Nat Biotechnol. 2024 Dec;42(12):1807-1821. doi: 10.1038/s41587-024-02485-9. Epub 2024 Dec 4.
10
AAV-mediated gene therapies by miniature gene editing tools.
Sci China Life Sci. 2024 Dec;67(12):2540-2553. doi: 10.1007/s11427-023-2608-5. Epub 2024 Sep 27.

本文引用的文献

1
Multiplex gene regulation by CRISPR-ddCpf1.
Cell Discov. 2017 Jun 6;3:17018. doi: 10.1038/celldisc.2017.18. eCollection 2017.
2
Engineered Cpf1 variants with altered PAM specificities.
Nat Biotechnol. 2017 Aug;35(8):789-792. doi: 10.1038/nbt.3900. Epub 2017 Jun 5.
3
Efficient Transcriptional Gene Repression by Type V-A CRISPR-Cpf1 from Eubacterium eligens.
ACS Synth Biol. 2017 Jul 21;6(7):1273-1282. doi: 10.1021/acssynbio.6b00368. Epub 2017 Apr 11.
4
A CRISPR-Cpf1 system for efficient genome editing and transcriptional repression in plants.
Nat Plants. 2017 Feb 17;3:17018. doi: 10.1038/nplants.2017.18.
5
Orthogonal Genetic Regulation in Human Cells Using Chemically Induced CRISPR/Cas9 Activators.
ACS Synth Biol. 2017 Apr 21;6(4):686-693. doi: 10.1021/acssynbio.6b00313. Epub 2017 Jan 19.
6
Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.
Nat Biotechnol. 2017 Jan;35(1):31-34. doi: 10.1038/nbt.3737. Epub 2016 Dec 5.
7
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.
Cell. 2017 Jan 12;168(1-2):20-36. doi: 10.1016/j.cell.2016.10.044. Epub 2016 Nov 17.
8
Editing DNA Methylation in the Mammalian Genome.
Cell. 2016 Sep 22;167(1):233-247.e17. doi: 10.1016/j.cell.2016.08.056.
9
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing.
Cell. 2016 Sep 22;167(1):219-232.e14. doi: 10.1016/j.cell.2016.09.006.
10
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
Nat Biotechnol. 2016 Aug;34(8):869-74. doi: 10.1038/nbt.3620. Epub 2016 Jun 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验